[Corticosteroid therapy for patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count)].

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Acta Médica Portuguesa

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.20344/AMP.1026PMID 16207453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Hypertensive Disorders of Pregnancy: Common Clinical Conundrums

  2022cites this paper
• Markers of adiposity in HIV/AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index

  2018cites this paper
• Prognostic Factors of the Efficacy of High-dose Corticosteroid Therapy in Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome During Pregnancy

  2016cites this paper
• Corticosteroid Therapy for Management of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP) Syndrome: A Meta-Analysis

  2015cites this paper
• Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial.

  2008cites this paper